Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MS n, and LC-HR-MS n

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 30, 2013, Pages 9779-9789

  Meyer, Golo M J ^a   Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Detectability; Gas chromatography mass spectrometry; Human; Liquid chromatography high resolution multistage mass spectrometry; Liquid chromatography multistage mass spectrometry; Metabolism; Xylazine

Indexed keywords

DETECTABILITY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMAN; MULTI-STAGE MASS SPECTROMETRY; XYLAZINE;

BIOMOLECULES; GAS CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; PHYSIOLOGY; RATS; VETERINARY MEDICINE;

BODY FLUIDS;

HYPNOTIC SEDATIVE AGENT; XYLAZINE;

ADOLESCENT; ANIMAL; ARTICLE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; RAT; SOLID PHASE EXTRACTION; SUBSTANCE ABUSE; URINE; WISTAR RAT;

ADOLESCENT; ANIMALS; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MASS SPECTROMETRY; RATS; RATS, WISTAR; SOLID PHASE EXTRACTION; SUBSTANCE ABUSE DETECTION; XYLAZINE;

EID: 84890022116     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7419-7     Document Type: Article

References (28)

1. Meyer GMJ, Meyer MR, Mischo B, Schofer O, Maurer HH (2013) Case report of accidental poisoning with the tranquilizer xylazine and the anesthetic ketamine confirmed by qualitative and quantitative toxicological analysis using GC-MS and LC-MSn. Drug Test Anal. doi: 10.1002/dta.1475
2. Reyes JC, Negron JL, Colon HM, Padilla AM, Millan MY, Matos TD, Robles RR (2012) The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico. J Urban Health 89:519-526
3. Hoffmann U, Meister CM, Golle K, Zschiesche M (2001) Severe intoxication with the veterinary tranquilizer xylazine in humans. J Anal Toxicol 25:245-249
4. Spyridaki MH, Lyris E, Georgoulakis I, Kouretas D, Konstantinidou M, Georgakopoulos CG (2004) Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis. J Pharm Biomed Anal 35:107-116
5. Andresen-Streichert H, Iwersen-Bergmann S, Anders S (2012) Forensische pädopathologie - xylazin-intoxikation bei einem kind. Päd 18:161-164
6. Wong SC, Curtis JA, Wingert WE (2008) Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office. J Forensic Sci 53:495-498
7. Capraro AJ, Wiley JF, Tucker JR (2001) Severe intoxication from xylazine inhalation. Pediatr Emerg Care 17:447-448
8. Liu CM, Chiu MJ, Fang CC, Chen WJ (2007) Xylazine abuse: a rare cause of syncope. Clin Toxicol (Phila) 45:309-311
9. Elejalde JI, Louis CJ, Elcuaz R, Pinillos MA (2003) Drug abuse with inhalated xylazine. Eur J Emerg Med 10:252-253
10. Poklis A, Mackell MA, Case ME (1985) Xylazine in human tissue and fluids in a case of fatal drug abuse. J Anal Toxicol 9:234-236
11. Stillwell ME (2003) A reported case involving impaired driving following self-administration of xylazine. Forensic Sci Int 134:25-28
12. Barroso M, Gallardo E, Margalho C, Devesa N, Pimentel J, Vieira DN (2007) Solid-phase extraction and gas chromatographic- mass spectrometric determination of the veterinary drug xylazine in human blood. J Anal Toxicol 31:165-169
13. Maurer HH (2012) How Can Analytical Diagnostics in Clinical Toxicology Be Successfully Performed Today? Ther Drug Monit 34:561-564
14. Mutlib AE, Chui YC, Young LM, Abbott FS (1992) Characterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS. Drug Metab Dispos 20:840-848
15. Lavoie DS, Pailleux F, Vachon P, Beaudry F (2013) Characterization of xylazine metabolism in rat liver microsomes using liquid chromatography-hybrid triple quadrupole-linear ion trap-mass spectrometry. Biomed Chromatogr 27:882-888
16. Choo HY, Choi S-O (1991) The metabolism of xylazine in rats. Arch Pharm Res 14:346-351
17. Maurer HH, Pfleger K, Weber AA (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
18. Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH (2011) Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal Bioanal Chem 400:3481-3489
19. Meyer GMJ, Meyer MR, Wissenbach DK, Maurer HH (2013) Studies on the metabolism and toxicological detection of glaucine, an isoquinoline alkaloid from Glaucium flavum (Papaveraceae), in rat urine using GC-MS, LC-MSn and LC-high-resolution MSn. J Mass Spectrom 48:24-41
20. Welter J, Meyer MR, Wolf E, Weinmann W, Kavanagh P, Maurer HH (2013) 2-Methiopropamine, a thiophene analogue of methamphetamine: Studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem 405:3125-3135
21. Meyer MR, Vollmar C, Schwaninger AE, Maurer HH (2012) New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J Mass Spectrom 47:253-262
22. Meyer MR, Dinger J, Schwaninger AE, Wissenbach DK, Zapp J, Fritschi G, Maurer HH (2012) Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)). Anal Bioanal Chem 402:1249-1255
23. Wissenbach DK, Meyer MR, Remane D, Weber AA, Maurer HH (2011) Development of the first metabolite-based LC-MSn urine drug screening procedure - exemplified for antidepressants. Anal Bioanal Chem 400:79-88
24. Meyer MR, Du P, Schuster F, Maurer HH (2010) Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat urine and human liver microsomes using GC-MS and LC-high-resolution-MS and its detectability in urine by GC-MS. J Mass Spectrom 45:1426-1442
25. Ewald AH, Ehlers D, Maurer HH (2008) Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 390:1837-1842
26. Meyer MR, Peters FT, Maurer HH (2010) Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin Chem 56:575-584
27. Spoerke DG, Hall AH, Grimes MJ, Honea BN III, Rumack BH (1986) Human overdose with the veterinary tranquilizer xylazine. Am J Emerg Med 4:222-224
28. Parker RJ, Collins JM, Strong JM (1996) Identification of 2,6-xylidine as a major lidocaine metabolite in human liver slices. Drug Metab Dispos 24:1167-1173